Results 141 to 150 of about 61,212,533 (299)

Aplicações da metodologia fish em citogenética de neoplasias. [PDF]

open access: yes, 2015
TCC(graduação) - Universidade Federal de Santa Catarina. Centro de Ciências Biológicas. Biologia.As neoplasias surgem em conseqüência de mutações acumulativas no material genético (DNA) de células normais, as quais sofrem alterações progressivas até se ...
Foppa, Carolina Ester
core  

[Construction and validation of a video about breast cancer for deaf womenConstrucción y validación de un video sobre el cáncer de mama para mujeres sordas]. [PDF]

open access: yesRev Cuid, 2023
Pereira-Gomes JD   +5 more
europepmc   +1 more source

Cobertura e fatores associados aos exames de detecção precoce do câncer de colo do útero e mama em Florianópolis, SC, 2009: um estudo transversal de base populacional [PDF]

open access: yes, 2013
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Saúde Coletiva, Florianópolis, 2010Introdução: a detecção precoce do câncer de colo de útero e mama, através do exame de ...
Gasperin, Simone Iara
core  

New Cardiovascular Biomarkers in Breast Cancer Patients Undergoing Doxorubicin-Based Chemotherapy. [PDF]

open access: yesArq Bras Cardiol, 2023
Pestana RMC   +6 more
europepmc   +1 more source

Integrated spherical nucleic acid nanoreactor mobilizes targeted PD‐L1 proteolysis and cuproptosis for robust breast cancer immunotherapy

open access: yesBMEMat, EarlyView.
This study provides an integrated spherical nucleic acid nanoreactor (denoted as AMCuD) for targeted PD‐L1 degradation and chemo‐dynamically enhanced cuproptosis to synergically elicit robust immunotherapy against the triple‐negative breast cancer (TNBC) growth, recurrence and metastasis.
Ningxi Li   +9 more
wiley   +1 more source

Mama-Ú #9

open access: yes, 2011
Hemos llegado al camino que nos habíamos propuesto recorrer con la revista Mama-Ú, el tema de San Pacho, historia y tradición. La cuarta entrega recopila temas fundamentales para la fiesta que estamos seguros serán motivo de apropiación colectiva ...
cultural Mama-Ú, Centro
core   +1 more source

Breast cancer: 2 case reports Cancer de mama: 2 casos clínicos

open access: yesAnais Brasileiros de Dermatologia, 2012
Breast cancer is the most frequently diagnosed life-threatening cancer in women and the leading cause of cancer death among them worldwide. It includes a heterogeneous collection of diseases with various histologically defined subsets, clinical presentations, responses to treatment and outcomes. We describe 2 cases of female patients with ductal breast
Aristóteles Rosmaninho   +3 more
openaire   +1 more source

Programmable three‐state nanoreactor for spatiotemporally controlled tumor therapy

open access: yesBMEMat, EarlyView.
The OMVs are shielded with a biocompatible Da–Ca shell, which prolongs its circulation period and promotes intratumoral accumulation. Importantly, the biocompatible Da–Ca shell can be controllably disintegrated in tumor microenvironment by using laser irradiation, generating in situ hyperthermia and releasing Ca2+.
Guihong Lu   +12 more
wiley   +1 more source

Correlação da mamografia com o exame clínico e incidência do câncer de mama na população de Xangri-Lá/RS

open access: yesClinical and Biomedical Research, 2012
Introdução: Foram publicados na Revista Brasileira de Mastologia dados importantes sobre a população feminina de Xangri-Lá/RS, demonstrando alta incidência de câncer de mama.
Nilton Leite Xavier   +2 more
doaj  

Tailoring drug‐to‐lipid ratio in redox‐responsive lipid‐mimetic prodrug liposomes for superior cabazitaxel delivery and antitumor efficacy

open access: yesBMEMat, EarlyView.
Redox‐responsive lipid‐mimetic prodrug liposomes with high drug‐to‐lipid ratios enhance cabazitaxel delivery, prolong circulation, and enable tumor‐selective drug release for superior antitumor efficacy and safety. Abstract Liposomes represent one of the most extensively investigated nanocarriers in drug delivery.
Shengyao Xu   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy